The global Non-Animal Alternative Testing Market is experiencing significant growth, projected to rise from USD 9.8 billion in 2021 to USD 29.4 billion by 2030, driven by ethical concerns over animal testing and advancements in non-animal testing technologies. The U.S. FDA’s commitment to moving away from routine animal studies and the acceptance of organ-on-a-chip technologies mark key regulatory shifts. Additionally, the cosmetics industry is leading the push for cruelty-free testing, while in silico methods and high-throughput technologies are enhancing testing accuracy. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region, reflecting increasing regulatory pressures and public concern about animal welfare.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.prnewswire.co.uk/news-releases/non-animal-alternative-testing-market-size-to-reach-29-4-billion-by-2030–globally-at-13-5-cagr-allied-market-research-302771246.html
